#168: Diabetes risk outweighed by CV benefit of statins; "threshold" effect for vitamin D and CVD: New meta-analysis; European approvals for apixaban in AF, rivaroxaban for PE/DVT; New guidelines emphasize OMT for stable IHD; FDA approves HeartWare VAD

Diabetes risk outweighed by CV benefit of statins; "threshold" effect for vitamin D and CVD: New meta-analysis; European approvals for apixaban in AF, rivaroxaban for PE/DVT; New guidelines emphasize OMT for stable IHD; FDA approves HeartWare VAD fo

Source: Radio TheHeart.org - November 23, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts